China National Medicines (SHSE:600511) Accounts Payable : ¥11,892 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Accounts Payable?

China National Medicines's Accounts Payable for the quarter that ended in Mar. 2025 was ¥11,892 Mil.

China National Medicines's quarterly Accounts Payable declined from Sep. 2024 (¥12,517 Mil) to Dec. 2024 (¥12,086 Mil) and declined from Dec. 2024 (¥12,086 Mil) to Mar. 2025 (¥11,892 Mil).

China National Medicines's annual Accounts Payable increased from Dec. 2022 (¥9,917 Mil) to Dec. 2023 (¥10,943 Mil) and increased from Dec. 2023 (¥10,943 Mil) to Dec. 2024 (¥12,086 Mil).

China National Medicines Accounts Payable Historical Data

The historical data trend for China National Medicines's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Accounts Payable Chart

China National Medicines Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

8,990.33

10,057.81

9,916.66

10,943.06

12,086.21

China National Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															10,604.49	11,922.70	12,517.33	12,086.21	11,892.12

China National Medicines Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

China National Medicines Accounts Payable Related Terms

Thank you for viewing the detailed overview of China National Medicines's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics and biochemical drugs.

Executives

Chen Zhang Qing

Director

China National Medicines Headlines

No Headlines